We are developing cutting-edge biosensors and bioelectronics based on electrochemical reaction. We are pioneering the development of next-generation biosensors and bioelectronics with diverse capabilities, including wearable, implantable, and wireless devices. We are focused on developing biosensing/bioelectronic interfaces that possess physical and chemical properties tailored to the sensor's intended use and sensing environment, enabling high-sensitivity detection.

Conventional biomedical devices are rigid or bulky, making generally impossible to apply directly to human issues and real-time biosensing. To enable direct application to human tissue and real-time biosensing, platforms with characteristics such as small size, flexibility, stretchability, or biodegradability are necessary. Here, we are developing next-generation biosensing/bioelectronic platforms including wearable, implantable, wireless, or neural probe devices with aforementioned characteristics using various methods such as nanofabrication.

Traditional diagnostic approaches often involve time-consuming laboratory tests conducted in centralized facilities, leading to delays in diagnosis and treatment initiation. We are developing point-of-care diagnostic devices that can overcome the limitation of the traditional ones. Our goal is to develop the personalized diagnostic/therapeutic biomedical devices that enable patients themselves to monitor the progression and diagnosis of diseases in real-time.